1-6 of 6
Tara Chapman-Arvedson
Close
Sort by
Journal Articles

The Race Is on: BiTE Vs CART As FLT3-Directed Immunotherapies in AML

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler, Bettina Brauchle, Florian Märkl, Nora Phillip, Gerulf Hänel, Anetta Marcinek, Maryam Kazerani, Rebecca Goldstein, Michael von Bergwelt, Sebastian Kobold, Veit L Buecklein, Tara Chapman-Arvedson, Marion Subklewe
Journal: Blood
Blood (2022) 140 (Supplement 1): 10233–10234.
https://doi.org/10.1182/blood-2022-158452
Published: 2022
Journal Articles

AMG 701 Potently Induces Anti-Multiple Myeloma (MM) Functions of T Cells and IMiDs Further Enhance Its Efficacy to Prevent MM Relapse In Vivo

Shih-Feng Cho, MD PhD, Liang Lin, PhD, Lijie Xing, MD, Kenneth Wen, Tengteng Yu, MD PhD, Phillip A Hsieh, Yuyin Li, PhD, Nikhil C. Munshi, MD, Joachim Wahl, PhD, Katja Matthes, Kenneth C. Anderson, MD, Tara Chapman-Arvedson, Yu-Tzu Tai, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 135.
https://doi.org/10.1182/blood-2019-128528
Published: 2019
Journal Articles

Evaluation of a FLT3 Bite® for Acute Myeloid Leukemia

Rebecca Goldstein, PhD, Anja Henn, Priya Koppikar, PhD, Ivonne Archibeque, BA, Brendon Frank, Mercedesz Balazs, Christoph Dahlhoff, PhD, Tobias Raum, PhD, Chi-Ming Li, PhD, Joachim Wahl, PhD, Dan Rock, Oliver Thomas, BSc, Christine Karbowski, PhD, Christina Krupka, PhD, Marion Subklewe, MD, Angela Coxon, PhD, Tara Chapman-Arvedson
Journal: Blood
Blood (2017) 130 (Supplement 1): 1354.
https://doi.org/10.1182/blood.V130.Suppl_1.1354.1354
Published: 2017
Journal Articles

Generation of Half-Life Extended Anti-BCMA Bite® Antibody Construct Compatible with Once-Weekly Dosing for Treatment of Multiple Myeloma (MM)

Ana Goyos, PhD, Chi-Ming Li, PhD, Petra Deegen, Diplom, Pamela Bogner, PhD, Oliver Thomas, BSc, Klinger Matthias, PhD, Joachim Wahl, PhD, Rebecca Goldstein, PhD, Angela Coxon, PhD, Mercedesz Balazs, Tara Chapman-Arvedson
Journal: Blood
Blood (2017) 130 (Supplement 1): 5389.
https://doi.org/10.1182/blood.V130.Suppl_1.5389.5389
Published: 2017
Journal Articles

Midostaurin Reduces Bite® Mediated Cytotoxicity Against Acute Myeloid Leukemia

Bettina Lindl, Christina Krupka, PhD, Tara Chapman-Arvedson, Roman Kischel, MD, Peter Kufer, MD, Sascha Haubner, MD, Felix S. Lichtenegger, MD, Thomas Koehnke, MD, Klaus H. Metzeler, MD, Nikola Konstandin, PhD, Karsten Spiekermann, Wolfgang Hiddemann, MD PhD, Marion Subklewe, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2656.
https://doi.org/10.1182/blood.V130.Suppl_1.2656.2656
Published: 2017
Journal Articles

Generation of a Half-Life Extended Anti-CD19 BiTE ® Antibody Construct Compatible with Once-Weekly Dosing for Treatment of CD19-Positive Malignancies

Grit Lorenczewski, MS, Matthias Friedrich, Roman Kischel, MD, Christoph Dahlhoff, PhD, Jonas Anlahr, MS, Mercedesz Balazs, Dan Rock, Michael C Boyle, DVM, PhD DACVP, DABT, Rebecca Goldstein, PhD, Angela Coxon, PhD, Tara Chapman-Arvedson
Journal: Blood
Blood (2017) 130 (Supplement 1): 2815.
https://doi.org/10.1182/blood.V130.Suppl_1.2815.2815
Published: 2017